RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Operating income

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.4B
P/E ratio
-3.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025-1,161+0.51%
Mar 31, 2024-1,155-21.27%
Mar 31, 2023-1,467-0.61%
Mar 31, 2022-1,476-14.82%
Mar 31, 2021-1,733-5.17%
Mar 31, 2020-1,827+9.71%
Mar 31, 2019-1,666+6.65%
Mar 31, 2018-1,562+40.25%
Mar 31, 2017-1,114+12.62%
Mar 31, 2016-989+100.89%
Mar 31, 2015-492

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)